NCT02526901Recruiting
The Born in Guangzhou Cohort Study (BIGCS)
Source: ClinicalTrials.gov · Last updated 26 Feb 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The Born in Guangzhou Cohort Study (BIGCS) was established to investigate the short- and long-term effects of exposure in early life on health consequences in Guangzhou, China. Data are collected regarding environmental, occupational and lifestyle exposures as well as health outcomes in later life. Biological samples including blood and tissue samples are also collected from the participants.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 30000 (estimated)
- First submitted
- 13 Aug 2015
- Start date
- 1 Feb 2012
- Primary completion date
- 31 Dec 2025
- Lead sponsor
- Guangzhou Women and Children's Medical Center
- Diseases
- Obesity
- NCT number
- NCT02526901
What you commit to
- Study type: Observational
- Planned participants: 30000
- From 1 Feb 2012 to the primary completion date, 31 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Who the study is looking for
- Pregnant women with \<20 weeks of gestation
- Pregnant women intended to eventually deliver in Guangzhou Women and Children's Medical Center
- Permanent residents or families intended to remain in Guangzhou with their child for ≥3 years
Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Guangzhou Women and Children's medical center Coordinator of this site? Confirm its status | Guangzhou | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.